Private Equity

Capital Markets Seminar

26 September 2022

Agenda and introduction

Simon Borrows

Chief Executive

Agenda

14.00-

Agenda and introduction

Simon Borrows

14.10

Chief Executive

14.10-

BoConcept

Boris Kawohl

14.50

Q&A

Partner, Managing Director Benelux, Head of Consumer

14.50-

Healthcare sector update

Richard Relyea

15.30

and Cirtec Medical

Partner, Managing Director North America, Head of Healthcare

Q&A

15.30-

WilsonHCG

Rahul Lulla

16.10

Q&A

Partner, North America

16.10-

Closing remarks and

Simon Borrows

16.30

final questions

Chief Executive

3

Portfolio update

  • Investment portfolios continue to make good progress in challenging markets
  • Private Equity portfolio:
    • Assets in value for money consumer, healthcare, specialty industrial and business and technology services have generated strong earnings growth and have good momentum as we head into H2 FY23. We also see sustained increase in demand across travel related assets in the portfolio
    • Assets exposed to discretionary spending continue to see headwinds, but encouraged by pricing power shown by a number of the more challenged companies, as well as ability to use other levers to partially mitigate inflation impacts
  • Action's impressive performance continues with very strong sales and EBITDA growth; significant new customer flow driven by very low prices and good product availability
    • YTD sales at over €5.8bn are over 26% ahead of the same period last year
    • Expect LTM EBITDA to the end of P9 to be c.€1,035m compared to €765m at September last year and €506 million at September 2019
    • Continued strong cash generation with net debt now standing at less than 2.1x run-rate EBITDA
    • 142 new stores opened to date in 2022; on track to open more new stores in 2022 than in 2021
    • Energy costs for 2022 estimated to total less than 0.4% of sales
  • International investments (non-sterling) account for 87% of 3i's investment portfolio

4

Today's seminar

2016

Urban living designer

2021

Global winner in talent solutions

2017

Outsourced medical device manufacturing

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

3i Group plc published this content on 26 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 September 2022 12:34:04 UTC.